Retour
Fourchette du Jour
48,83 €
50,03 €
Fourchette 52 Semaines
38,24 €
62,15 €
Volume
4 077
Moyenne 50J / 200J
55,56 €
/
51,89 €
Clôture Précédente
48,44 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 485,2 | 0,3 |
| P/B | 26,7 | 2,9 |
| ROE % | 5,4 | 3,7 |
| Net Margin % | 4,4 | 3,8 |
| Rev Growth 5Y % | -0,4 | 10,0 |
| D/E | 1,7 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
3,5 B | 0 |
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
3,2 B | 0 |
Points Clés
Revenue declined -0,37% annually over 5 years
Earnings grew 77,13% over the past year
Generating 205,65M in free cash flow
P/E of 485,17 — premium valuation
Cash machine — converts 138,22% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
-0,37%
Revenue (1Y)0,53%
Earnings (1Y)77,13%
FCF Growth (3Y)-16,35%
Qualité
Return on Equity
5,44%
ROIC6,56%
Net Margin4,38%
Op. Margin18,41%
Sécurité
Debt / Equity
1,65
Current Ratio0,90
Interest Coverage3,29
Valorisation
P/E Ratio
485,17
P/B Ratio26,68
EV/EBITDA121,62
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,53% | Revenue Growth (3Y) | 0,04% |
| Earnings Growth (1Y) | 77,13% | Earnings Growth (3Y) | -14,85% |
| Revenue Growth (5Y) | -0,37% | Earnings Growth (5Y) | -17,35% |
| Profitability | |||
| Revenue (TTM) | 3,40B | Net Income (TTM) | 148,79M |
| ROE | 5,44% | ROA | 1,53% |
| Gross Margin | 46,26% | Operating Margin | 18,41% |
| Net Margin | 4,38% | Free Cash Flow (TTM) | 205,65M |
| ROIC | 6,56% | FCF Growth (3Y) | -16,35% |
| Safety | |||
| Debt / Equity | 1,65 | Current Ratio | 0,90 |
| Interest Coverage | 3,29 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 485,17 | P/B Ratio | 26,68 |
| P/S Ratio | 21,24 | PEG Ratio | 1,47 |
| EV/EBITDA | 121,62 | Dividend Yield | 0,00% |
| Market Cap | 72,19B | Enterprise Value | 76,10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,40B | 3,38B | 3,40B | 4,17B | 3,45B |
| Net Income | 148,79M | 84,00M | 205,20M | 678,10M | 318,90M |
| EPS (Diluted) | 0,43 | 0,24 | 0,60 | 2,67 | 1,25 |
| Gross Profit | 1,57B | 1,52B | 1,57B | 2,20B | 1,84B |
| Operating Income | 625,69M | 437,20M | 543,90M | 1,14B | 933,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9,71B | 10,10B | 9,76B | 6,98B | 5,70B |
| Total Liabilities | 5,85B | 6,21B | 7,00B | 4,32B | 3,98B |
| Shareholders' Equity | 2,71B | 2,76B | 2,07B | 1,99B | 1,26B |
| Total Debt | 4,45B | 4,56B | 5,31B | 2,54B | 2,08B |
| Cash & Equivalents | 541,17M | 813,40M | 379,20M | 165,90M | 342,80M |
| Current Assets | 1,77B | 2,11B | 1,96B | 2,02B | 1,80B |
| Current Liabilities | 1,97B | 1,44B | 1,33B | 1,80B | 1,55B |